RECENT NEWS
State-of-the-art prehabilitation programme
The James Paget University Hospital in Norfolk is piloting a state-of-the-art prehabilitation programme that helps newly diagnosed cancer patients prepare for their treatment. Initially the service will be offered to people in the Great Yarmouth and Waveney area diagnosed with colorectal cancer with plans to extend this to other cancer patients as the pilot evolves.
Eight surgical hubs win recognition for meeting top clinical standards
Eight elective surgical hubs have been awarded accreditation as part of a pilot scheme to ensure the highest standards in clinical and operational practice.
Liver scans find one in 10 people have liver damage that could lead to deadly cancer
A new initiative to check for liver cancer in high-risk communities has been rolled out as part of a major NHS drive to catch more cancers earlier and save lives.
NHS virtual wards treat 100,000 patients in a year
More than 100,000 patients have been treated in NHS virtual wards in the last year, with 16,000 patients treated in January alone. Virtual wards allow patients to get hospital-level care at home safely and in familiar surroundings, helping speed up their recovery while freeing up hospital beds for patients that need them most.
£16 million boost for pioneering AI research
Tens of thousands of patients across the country could benefit from quicker, earlier diagnoses and more effective treatments for a range of conditions, as the Government invests nearly £16 million into pioneering artificial intelligence (AI) research.
ABHI UK Pavilion at Arab Health 2023 Marks Strongest Year to Date
The ABHI UK Pavilion at Arab Health 2023 saw its most vibrant and successful year to date, with organisers confirming record attendance.
Gut microbiome influences how lymphoma patients respond to CAR T therapy
Microorganisms live in or on almost every part of the human body and play an important role in the regulation of normal human processes. As a result, changes in the number or type of microorganisms, also known as the microbiome, can contribute to disease and altered responses to therapy, including cancer treatment.
Impact of COVID-19 pandemic on incidence of long-term conditions in Wales
A population data linkage study using anonymised primary and secondary care health records in Swansea University’s SAIL Databank has revealed that in 2020 and 2021, fewer people in Wales were diagnosed with long-term conditions than expected.
Respiratory disease in early childhood linked to higher risk of death in adulthood
Contracting a lower respiratory tract infection in early childhood is associated with a higher risk of dying from respiratory disease as an adult, according to new research.
Clogged leg arteries underdiagnosed and undertreated in women
Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in women, according to a review published in European Heart Journal – Quality of Care and Clinical Outcomes, a journal of the European Society of Cardiology (ESC). The paper highlights the biological, clinical and societal reasons why the condition may be missed in women, who respond less well to treatment and have worse clinical outcomes.
Over 9 in 10 independent sector hospitals now rated ‘Good’ or ‘Outstanding’ by CQC
Analysis by the Independent Healthcare Providers Network (IHPN) has shown that for the first time, nine out of 10 independent hospitals have ‘Good’ or ‘Outstanding’ overall ratings from the health and care regulator, the Care Quality Commission (CQC).
New NHS centre for making products for revolutionary cell and gene therapies
NHS Blood and Transplant (NHSBT) has opened a state-of-the-art facility which will contribute greatly to the UK’s ability to develop and manufacture new gene and cell therapies.
Government considers new approach to prevent life-threatening cardiovascular disease
People across England stand to benefit from a project to identify radical new approaches to prevent cardiovascular disease and reduce pressure on the NHS, following the appointment of Professor John Deanfield as Government Champion for Personalised Prevention.
£25 million for women's health hub expansion
Women across England will benefit from tailored healthcare and support by new women’s health hubs - improving access and quality of care for services for menstrual problems, contraception, pelvic pain, menopause care and more.
Growing number of NHS staff unhappy with care standards
Less than two thirds of staff in the NHS would be happy with the standard of care in their organisation if a friend or relative needed treatment, according to the national NHS staff survey 2022. The proportion who would recommend their organisation as a place to work is also declining, and almost one in three staff “often think about leaving”.
World first surgery at Guy’s and St Thomas’
A team from Guy’s and St Thomas’ have become the first in the world to operate through a patient’s mouth using the Versius robotic surgery system.
Opioid prescriptions cut by almost half a million in four years
GPs and pharmacists have helped cut opioid prescriptions in England by 450,000 in under four years, latest data shows, as the NHS unveils a new action plan to crack down on the overuse of potentially-addictive medicines.
NHS pilots artificial intelligence software to cut missed hospital appointments
Artificial intelligence (AI) that predicts likely missed appointments and offers back-up bookings will be piloted by the NHS in a bid to maximise resources and potentially save billions.
England Rare Diseases Action Plan to tackle health inequalities
A new Rare Diseases Action Plan for England has been published that will ensure those living with these conditions receive better care and treatment, fairer access to testing and have continued support.
Reproductive factors in women contribute to risk of cardiovascular disease
An earlier first birth, a higher number of live births, and starting periods at a younger age are all linked to a higher risk of cardiovascular problems in women, according to new research.
Latest Issues
Founded in Sheffield during 1932, Swann-Morton have become a world leader in the manufacture of surgical blades, scalpels and handles. It is a name respected globally for quality, precision, consistency and reliability and recognised for combining traditional blade making skills with the latest technology.
AfPP Regional Conference – Nottingham
Business School, University of Nottingham
20th September 2025
Clinical Engineering Conference
Stansted Radisson Blu
23rd September 2025
Infection Prevention 2025
Brighton Centre, UK
29th - 30th September 2025
AfPP Regional Conference – Oxford
Mathematical Institute, University of Oxford
4th October 2025
BACCN Conference 2025
Blackpool
7th - 8th October 2025
CSC Autumn Meeting
Ramada Plaza, Wrexham
13th October 2025